Vizsgálati helyszín
Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida 33140, Egyesült ÁllamokMég nincs intézményhez kötve
- 19futó vizsgálat
- 8lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 27 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis8 vizsgálat
- 2. fázis7 vizsgálat
- 1/2. fázis6 vizsgálat
- 1. fázis3 vizsgálat
- 2/3. fázis2 vizsgálat
- 4. fázis1 vizsgálat
- Állapot
- Fut, nem toboroz10 vizsgálat
- Toboroz8 vizsgálat
- Lezárult6 vizsgálat
- Leállították2 vizsgálat
- Meghívásos bevonás1 vizsgálat
- Fő szponzor
- Genmab3 vizsgálat
- Celgene2 vizsgálat
- Pfizer2 vizsgálat
- Aadi Bioscience, Inc.1 vizsgálat
- Acrivon Therapeutics1 vizsgálat
- és még 18
Futó vizsgálatok
Toboroz
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT07023627· 2. fázis· Incyte Corporation· Forrás
Toboroz
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
NCT06952660· 4. fázis· Pfizer· Forrás
Fut, nem toboroz
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
NCT06619236· 3. fázis· Genmab· Forrás
Toboroz
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
NCT06463028· 2. fázis· Faeth Therapeutics· Forrás
Contact: Medical Monitor
Toboroz
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT06161025· 2/3. fázis· Daiichi Sankyo· Forrás
Toboroz
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
NCT05997017· 2. fázis· Aadi Bioscience, Inc.· Forrás
Contact: Michelle McClosky
Fut, nem toboroz
Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma
NCT05948475· 3. fázis· TransThera Sciences (Nanjing), Inc.· Forrás
Toboroz
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
NCT05602363· 1. fázis· Carna Biosciences, Inc.· Forrás
Contact: Yvonne Enriquez
Fut, nem toboroz
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
NCT05945823· 2. fázis· Taiho Oncology, Inc.· Forrás
Fut, nem toboroz
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
NCT05611931· 3. fázis· Karyopharm Therapeutics Inc· Forrás
Toboroz
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
NCT05633654· 3. fázis· Gilead Sciences· Forrás
Meghívásos bevonás
A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors
NCT05741242· 1/2. fázis· Jaime Leandro Foundation for Therapeutic Cancer Vaccines· Forrás
Toboroz
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
NCT05548296· 2. fázis· Acrivon Therapeutics· Forrás
Contact: Evelyn Goya
Fut, nem toboroz
A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
NCT05141721· 2/3. fázis· Seattle Project Corporation· Forrás
Toboroz
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
NCT04486352· 1/2. fázis· Alliance Foundation Trials, LLC.· Forrás
Contact: Quality Management and Compliance
Fut, nem toboroz
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
NCT04607421· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541· 1/2. fázis· Genmab· Forrás
Fut, nem toboroz
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
NCT04083599· 1/2. fázis· Genmab· Forrás
Fut, nem toboroz
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
NCT03281954· 3. fázis· NSABP Foundation Inc· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Leállították
Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer
NCT05631574· 1. fázis· Biomea Fusion Inc.· Forrás
Leállították
Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer
NCT04791384· 1/2. fázis· Criterium, Inc.· Forrás
Lezárult
A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)
NCT05323656· 2. fázis· Calliditas Therapeutics Suisse SA· Forrás
Lezárult
A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
NCT05198804· 1/2. fázis· K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc· Forrás
Toboroz
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
NCT04830137· 1. fázis· Nurix Therapeutics, Inc.· Forrás
Contact: Patient Outreach
Lezárult
Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma
NCT02360579· 2. fázis· Iovance Biotherapeutics, Inc.· Forrás
Lezárult
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
NCT01996865· 3. fázis· Celgene· Forrás
Lezárult
Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission
NCT01757535· 3. fázis· Celgene· Forrás
Hibát jelzek